Ginkgo Bioworks Announces Date of Third Quarter 2021 Results Presentation
Ginkgo Bioworks (NYSE: DNA) is set to host a presentation on November 15, 2021, at 8:00 a.m. ET to discuss its third-quarter business performance for the period ending September 30, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Ginkgo Bioworks (NYSE: DNA) is set to host a presentation on November 15, 2021, at 8:00 a.m. ET to discuss its third-quarter business performance for the period ending September 30, 2021. Investors can find presentation details and registration on Ginkgo's investor relations website, where a replay will also be available. Questions can be submitted beforehand via Twitter or email. Ginkgo is advancing biotechnology applications in sectors like food, agriculture, and pharmaceuticals, contributing to COVID-19 response efforts such as pooled testing and vaccine optimization.
Positive
- Upcoming presentation on November 15, 2021, allows investors to gauge Q3 performance.
- Focus on diverse biotech applications may attract new partnerships and investments.
- Active involvement in COVID-19 response enhances company reputation and market positioning.
Negative
- None.
Details
News Market Reaction – DNA
The recorded move for DNA in the trading session of this news was +6.95%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Nov. 8, 2021 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2021, on Monday, November 15, 2021, beginning at 8:00 a.m. ET.
The presentation details and registration link will be available on Ginkgo's investor relations website at www.ginkgobioworks.com/investors and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit www.ginkgobioworks.com.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
investors@ginkgobioworks.com
MEDIA CONTACT:
press@ginkgobioworks.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-third-quarter-2021-results-presentation-301418408.html
SOURCE Ginkgo Bioworks
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.